The Truvada wars

BMJ (Online)

Volumn 348, Issue , 2014, Pages

  Belluz, Julia ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DRUG EFFICACY; DRUG SAFETY; HIGH RISK POPULATION; HOMOSEXUAL MALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; MEDICATION COMPLIANCE; MEN WHO HAVE SEX WITH MEN; NAUSEA; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEXUAL BEHAVIOR; SOCIAL STIGMA; UNITED STATES; UNPROTECTED SEX; UNSPECIFIED SIDE EFFECT;

ADULT; ANTI-RETROVIRAL AGENTS; DEOXYCYTIDINE; DRUG COMBINATIONS; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; ORGANOPHOSPHORUS COMPOUNDS; TREATMENT OUTCOME;

EID: 84903289352     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g3811     Document Type: Article

References (9)

1. Crary D. Truvada, HIV prevention drug, divides gay community. Huffington Post 7 April 2014. www.huffingtonpost.com/2014/04/07/truvada-gay-men-hiv-n- 5102515.html.
2. Centers for Disease Control and Prevention. Pre-exposure prophylaxis (PrEP). www.cdc.gov/hiv/prevention/research/prep/.
3. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010;363:2587-99.
4. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 2012;367:399-410.
5. Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2013;381:2083-90.
6. Okwundu CI, Uthman OA, Okoromah CA. Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals. Cochrane Database Syst Rev 2012;7:CD007189.
7. The ADAPT Study: Use of Emtricitabine and Tenofovir Disoproxil Fumarate for Pre-Exposure Prophylaxis (PrEP).http://clinicaltrials.gov/show/NCT01327651.
8. Public Health England. The PROUD Study: Examining the impact on gay men of using Pre-Exposure Prophylaxis (PrEP). www.proud.mrc.ac.uk/.
9. Mascolini M. Almost half of early US PrEP are women, often in southern states. 53rd ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy September 10-13, 2013. Denver CO. www.natap.org/2013/ICAAC/ICAAC- 04.htm.